Emerging drugs for psoriatic arthritis. - Wikidata - awgldk - TriplyDB

Emerging drugs for psoriatic arthritis.

Emerging drugs for psoriatic arthritis.

http://www.wikidata.org/entity/Q37763192

about

Review of the treatment of psoriatic arthritis with biological agents: choice of drug for initial therapy and switch therapy for non-responders.A novel biological target for the treatment of psoriatic arthritis.

P2860

Q30399745-C13CF291-B0B4-4CA3-AAF9-D5003464227F Q44268181-67607D8D-B5F0-4EAD-9960-E91F20833ADF

P2860

Emerging drugs for psoriatic arthritis.

http://www.wikidata.org/entity/Q37763192

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Emerging drugs for psoriatic arthritis.

@en

Emerging drugs for psoriatic arthritis.

@nl

type

label

Emerging drugs for psoriatic arthritis.

@en

Emerging drugs for psoriatic arthritis.

@nl

prefLabel

Emerging drugs for psoriatic arthritis.

@en

Emerging drugs for psoriatic arthritis.

@nl

P1433

Q37763192-CB3FAFC0-A57F-4374-9F49-079BBF8A6564

P1476

Q37763192-EA64EE58-AE23-42DD-8952-B22E457FA208

P2093

Q37763192-2E0EFEFE-ACC0-4910-8AA6-4A0E7F9EF481

Q37763192-D81CB15E-8097-48AB-A7DF-D2B2264CAC12

Q37763192-E4302643-F932-42C8-B245-5A88B74F2E85

P2860

Q37763192-034A7C47-FE3E-436D-9260-74356DA8CA7E

Q37763192-043DBEC4-45B4-4FFF-A7E2-B4D0FD86BBB5

Q37763192-0A70C727-4952-400B-B5D6-2966BCAB9EEB

Q37763192-1D96F7AE-EB1E-4CEF-B179-F710B0B9EB25

Q37763192-1FDF96C4-8061-4E1D-B5C1-4058D6C8C656

Q37763192-26539D0F-D9B9-4656-808E-F38AE109B452

Q37763192-2AED3099-291D-40B8-94A1-43874C4900A0

Q37763192-2EB62858-BE09-4190-B92D-EFFEF2451AC6

Q37763192-2F9FB783-950E-46CE-BB79-A66E004B37BD

Q37763192-3541E6CC-BF2A-45FD-BFDC-6E7B89AD8A7B

P304

Q37763192-EAD5AA63-49FF-4C36-88A3-DE4CFF632384

P31

Q37763192-87917F96-BD21-4789-973E-52B13F087713

P356

Q37763192-03FE282A-E6B7-491A-8F6D-CF1C92FB236D

P407

Q37763192-E2388E47-190B-494C-9940-D0AD903FE482

P433

Q37763192-BDE2027A-975F-49CE-8A9F-D06C78B0DC26

P478

Q37763192-FAE2210C-B27F-4184-976A-8341985BA6A3

P50

Q37763192-0653DDC2-88A7-473C-AA67-4481CA9E993F

Q37763192-55EBE495-AD03-4C48-85ED-EB46459C062C

P577

Q37763192-AA76C2B8-D834-4B78-A85F-F29331F477B0

P698

Q37763192-B6666E5D-2D1F-45FE-A536-32A4FDAB6760

P356

14728214.2010.497139

P1433

Expert Opinion on Emerging Drugs

P1476

Emerging drugs for psoriatic arthritis

@en

P2093

Carlo Palazzi

http://www.w3.org/2001/XMLSchema#string

Ignazio Olivieri

http://www.w3.org/2001/XMLSchema#string

Salvatore D'Angelo

http://www.w3.org/2001/XMLSchema#string

P2860

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation

Emerging PEGylated drugs.

The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis.

Seronegative spondyloarthritides.

Clinical and laboratory manifestations of elderly onset psoriatic arthritis: a comparison with younger onset disease.

Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: relation to inflammation and response to treatment.

P304

399-414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728214.2010.497139

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Ennio Lubrano Di Scorpaniello

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20528612

http://www.w3.org/2001/XMLSchema#string